Systemic Triple Therapy in Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Systemic Triple Therapy in Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Blog Article

For many years, androgen deprivation therapy (ADT) as monotherapy has been the gold standard for metastatic hormone-sensitive prostate cancer (mHSPC) treatment.Several studies have been published within Aloe Vera the last decade demonstrating a significant survival advantage resulting from combining the treatment with standard ADT plus docetaxel or androgen receptor targeted therapy (ARTA) compared to ADT monotherapy.Recently published data of the PEACE-1 and ARASENS trials suggest that in the future, triple therapy might be Bosch KSV36VLEP 60cm Serie 4 Freestanding Larder Fridge (Silver) SuperCooling a treatment option for patients with mHSPC.